Association between genetic variants and development of antibodies to infliximab: A cross-sectional study in Chinese patients with Crohn’s diseaseKouzhu Zhu, Liyan Miao, Qinhua Xi et al.|Frontiers in Pharmacology|2023Cited by 11
Reply to the comment from Bjerre et al.Xiaoliang Ding, Zhiyao Chen, Cheng Xie|Pharmacogenetics and Genomics|2015Cited by 0